1 – 32 of 32
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
- 2021
-
Mark
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy : Results from the EUROpean Bone Over 40 Sarcoma Study
(
- Contribution to journal › Article
- 2020
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
(
- Contribution to journal › Article
- 2018
-
Mark
Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years
(
- Contribution to journal › Article
-
Mark
EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
(
- Contribution to journal › Article
- 2015
-
Mark
Prognostic factors and follow-up strategy for superficial soft-tissue sarcomas: Analysis of 622 surgically treated patients from the scandinavian sarcoma group register.
(
- Contribution to journal › Article
-
Mark
RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts.
(
- Contribution to journal › Article
-
Mark
Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma.
(
- Contribution to journal › Article
- 2014
-
Mark
Fetthaltiga mjukdelstumörer i rörelseapparaten ofta godartade.
(
- Contribution to journal › Article
-
Mark
Integrative Genome and Transcriptome Analyses Reveal Two Distinct Types of Ring Chromosome in Soft Tissue Sarcomas.
(
- Contribution to journal › Article
-
Mark
Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma.
(
- Contribution to journal › Article
- 2013
-
Mark
A Benign Vascular Tumor With a New Fusion Gene: EWSR1-NFATC1 in Hemangioma of the Bone.
(
- Contribution to journal › Article
-
Mark
Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the wnt/beta-catenin signaling pathway.
(
- Contribution to journal › Article
-
Mark
Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor.
(
- Contribution to journal › Article
- 2012
-
Mark
The MDM2 SNP309 G allele is not preferentially amplified in bone and soft tissue tumors.
(
- Contribution to journal › Article
-
Mark
Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.
(
- Contribution to journal › Article
-
Mark
SNP array and FISH findings in two pleomorphic hyalinizing angiectatic tumors.
(
- Contribution to journal › Article
-
Mark
Recurrent Rearrangement of the PHF1 Gene in Ossifying Fibromyxoid Tumors.
(
- Contribution to journal › Article
- 2011
-
Mark
Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
(
- Contribution to journal › Article
-
Mark
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma 63 patients with a minimum follow-up of 4 years
(
- Contribution to journal › Article
- 2009
-
Mark
Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
(
- Contribution to journal › Article
-
Mark
Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
(
- Contribution to journal › Article
- 2007
-
Mark
Tiling resolution array comparative genomic hybridization analysis of a fibrosarcoma of bone.
(
- Contribution to journal › Article
-
Mark
Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype
(
- Contribution to journal › Article
- 2006
-
Mark
Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas
(
- Contribution to journal › Article
- 2004
-
Mark
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
(
- Contribution to journal › Article
- 2003
-
Mark
Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas
(
- Contribution to journal › Article
-
Mark
Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma
(
- Contribution to journal › Article
- 2002
-
Mark
Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
(
- Contribution to journal › Article
- 2001
-
Mark
No EWS/FLI1 fusion transcripts in giant-cell tumors of bone
(
- Contribution to journal › Article